Risk-Based Prostate Cancer Screening

This publication has 115 references indexed in Scilit:

• A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
  Journal of Urology, 2011
• EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
  European Urology, 2011
• Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50
  Cancer, 2010
• [-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
  Journal of Urology, 2010
• Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection?
  Journal of Urology, 2010
• Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
  British Journal of Cancer, 2009
• Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort
  European Urology, 2009
• Screening and Prostate-Cancer Mortality in a Randomized European Study
  New England Journal of Medicine, 2009
• Variation in KLK genes, prostate-specific antigen and risk of prostate cancer
  Nature Genetics, 2008
• Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of Curability
  JNCI: Journal of the National Cancer Institute, 2006